Vahabi M, Blandino G, Di Agostino S
Transl Cancer Res. 2022; 10(6):3090-3110.
PMID: 35116619
PMC: 8797920.
DOI: 10.21037/tcr-20-2530.
Mariani M, Castagna C, Boccia S, Pastorino R
J Pers Med. 2021; 11(8).
PMID: 34442465
PMC: 8400907.
DOI: 10.3390/jpm11080821.
Citron F, Segatto I, Musco L, Pellarin I, Rampioni Vinciguerra G, Franchin G
EMBO Mol Med. 2021; 13(7):e12872.
PMID: 34062049
PMC: 8261495.
DOI: 10.15252/emmm.202012872.
Takeuchi T, Kawasaki H, Luce A, Cossu A, Misso G, Scrima M
Int J Mol Sci. 2020; 21(10).
PMID: 32456271
PMC: 7279294.
DOI: 10.3390/ijms21103693.
Lamichhane S, Thachil T, Gee H, Milic N
Dis Markers. 2019; 2019:8632018.
PMID: 31827646
PMC: 6885815.
DOI: 10.1155/2019/8632018.
miR-96-5p targets PTEN expression affecting radio-chemosensitivity of HNSCC cells.
Vahabi M, Pulito C, Sacconi A, Donzelli S, DAndrea M, Manciocco V
J Exp Clin Cancer Res. 2019; 38(1):141.
PMID: 30925916
PMC: 6440033.
DOI: 10.1186/s13046-019-1119-x.
Meta-analysis of microRNAs expression in head and neck cancer: uncovering association with outcome and mechanisms.
Lubov J, Maschietto M, Ibrahim I, Mlynarek A, Hier M, Kowalski L
Oncotarget. 2017; 8(33):55511-55524.
PMID: 28903437
PMC: 5589676.
DOI: 10.18632/oncotarget.19224.
An Integrated Approach Identifies Mediators of Local Recurrence in Head and Neck Squamous Carcinoma.
Citron F, Armenia J, Franchin G, Polesel J, Talamini R, DAndrea S
Clin Cancer Res. 2017; 23(14):3769-3780.
PMID: 28174235
PMC: 7309652.
DOI: 10.1158/1078-0432.CCR-16-2814.
The microRNA signatures: aberrantly expressed microRNAs in head and neck squamous cell carcinoma.
Koshizuka K, Hanazawa T, Fukumoto I, Kikkawa N, Okamoto Y, Seki N
J Hum Genet. 2016; 62(1):3-13.
PMID: 27557665
DOI: 10.1038/jhg.2016.105.
Oral squamous cell carcinoma: microRNA expression profiling and integrative analyses for elucidation of tumourigenesis mechanism.
Manikandan M, Deva Magendhra Rao A, Arunkumar G, Manickavasagam M, Rajkumar K, Rajaraman R
Mol Cancer. 2016; 15:28.
PMID: 27056547
PMC: 4823852.
DOI: 10.1186/s12943-016-0512-8.
MicroRNA-186 induces sensitivity of ovarian cancer cells to paclitaxel and cisplatin by targeting ABCB1.
Sun K, Jiao J, Chen S, Liu B, Zhao Y
J Ovarian Res. 2015; 8:80.
PMID: 26626440
PMC: 4667519.
DOI: 10.1186/s13048-015-0207-6.
MicroRNA-133b targets glutathione S-transferase π expression to increase ovarian cancer cell sensitivity to chemotherapy drugs.
Chen S, Jiao J, Sun K, Zong Z, Zhao Y
Drug Des Devel Ther. 2015; 9:5225-35.
PMID: 26396496
PMC: 4577257.
DOI: 10.2147/DDDT.S87526.
Integrative analysis of the microRNA-mRNA response to radiochemotherapy in primary head and neck squamous cell carcinoma cells.
Summerer I, Hess J, Pitea A, Unger K, Hieber L, Selmansberger M
BMC Genomics. 2015; 16:654.
PMID: 26328888
PMC: 4557600.
DOI: 10.1186/s12864-015-1865-x.
MiR-21/miR-375 ratio is an independent prognostic factor in patients with laryngeal squamous cell carcinoma.
Hu A, Huang J, Xu W, Jin X, Li J, Tang Y
Am J Cancer Res. 2015; 5(5):1775-85.
PMID: 26175945
PMC: 4497443.
Mechanisms of Invasion in Head and Neck Cancer.
Jimenez L, Jayakar S, Ow T, Segall J
Arch Pathol Lab Med. 2015; 139(11):1334-48.
PMID: 26046491
PMC: 7469951.
DOI: 10.5858/arpa.2014-0498-RA.
Inhibition of nucleoporin member Nup214 expression by miR-133b perturbs mitotic timing and leads to cell death.
Bhattacharjya S, Roy K, Ganguly A, Sarkar S, Panda C, Bhattacharyya D
Mol Cancer. 2015; 14:42.
PMID: 25743594
PMC: 4335456.
DOI: 10.1186/s12943-015-0299-z.
[Cancer stem cell phenotypes and miRNA: therapeutic targets in head and neck squamous cell carcinoma].
Coordes A, Zhifeng S, Sangvatanakul V, Qian X, Lenarz M, Kaufmann A
HNO. 2014; 62(12):867-72.
PMID: 25337967
DOI: 10.1007/s00106-014-2931-4.
Anomalous altered expressions of downstream gene-targets in TP53-miRNA pathways in head and neck cancer.
Mitra S, Mukherjee N, Das S, Das P, Panda C, Chakrabarti J
Sci Rep. 2014; 4:6280.
PMID: 25186767
PMC: 5385823.
DOI: 10.1038/srep06280.
MicroRNA expression profile in head and neck cancer: HOX-cluster embedded microRNA-196a and microRNA-10b dysregulation implicated in cell proliferation.
Severino P, Bruggemann H, Andreghetto F, Camps C, Klingbeil M, de Pereira W
BMC Cancer. 2013; 13:533.
PMID: 24209638
PMC: 3826519.
DOI: 10.1186/1471-2407-13-533.
Expression of TP53 mutation-associated microRNAs predicts clinical outcome in head and neck squamous cell carcinoma patients.
Ganci F, Sacconi A, Bossel Ben-Moshe N, Manciocco V, Sperduti I, Strigari L
Ann Oncol. 2013; 24(12):3082-8.
PMID: 24107801
PMC: 3841017.
DOI: 10.1093/annonc/mdt380.